Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on treatment of children with aplastic anemia. This video was recorded at the ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

Please provide your email address to receive an email when new articles are posted on . Outcomes after haploidentical transplant for severe aplastic anemia have improved significantly with use of post ...

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival ...

Severe aplastic anemia used to have few options and mortality was high, but a new class of drugs offers some hope. A recent review examined treatment options for aplastic anemia (AA), a hematopoietic ...

On the surface, Owen Ho looked fine. But on the inside, it was a different story. Ho, 42, was exhausted. He couldn’t muster up the strength to exercise even though months earlier, six-hour bike rides ...

Eltrombopag combined with immunosuppressive therapy in pediatric patients with severe aplastic anemia achieved a 54.9% overall response rate at 26 weeks, with a 71.4% response in relapsed/refractory ...

Add Yahoo as a preferred source to see more of our stories on Google. Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell ...

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

Aplastic anemia is a rare disorder characterized by inadequate production of blood cells by the bone marrow. The bone marrow is a spongy tissue inside the bones, where all the blood cells (red blood ...